26 completed, 6 terminated, 3 unknown, 1 withdrawn. 36 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 36 | Completed 26, Terminated 6, Unknown 3, Withdrawn 1 |
| Phase 2 | 2 | Terminated 2 |
Follow Cerebrovascular Accident: new trials by email Literature Review of Cerebrovascular Accident trials Research Report on Cerebrovascular Accident
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity, Cerebrovascular Accident | Phase 2 / Phase 3 | Terminated | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 32 | 2021-11-02 | 2026-05-27 |
| Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) Best Practice, Tocilizumab - Cerebrovascular Accident, Chronic Obstructive Pulmonary Disease | Phase 3 | Withdrawn | Emory University | 2020-04-07 | 2020-06-18 | |
| Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Lower Extremities Botulinum toxin type A - Cerebrovascular Accident | Phase 3 | Unknown | Chang Gung Memorial Hospital | 40 | 2015-10-01 | 2015-10-14 |
| A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity Botulinum Toxin Type A for Injection, placebo - Cerebrovascular Accident | Phase 3 | Completed | Lanzhou Institute of Biological Products Co., Ltd | 180 | 2014-07-01 | 2016-09-26 |
| Effectiveness Study on a Virtual Reality Based Training System for Stroke Patients YouGrabber training device from YouRehab Ltd., Therapy (PT, OT) - Cerebrovascular Accident, Hemorrhagic Stroke | Phase 3 | Completed | Reha Rheinfelden | 54 | 2013-01-01 | 2016-04-07 |
| Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities Botulinum Toxin Type A - Cerebrovascular Accident | Phase 3 | Unknown | Chang Gung Memorial Hospital | 40 | 2012-09-01 | 2016-03-30 |
| Botulinum Toxin Injections by Ultrasounds Guidance and Stretching Exercise in Spastic Toe Clawing Botulinum Toxin Type A, Stretching exercise - Cerebrovascular Accident | Phase 3 | Completed | Chang Gung Memorial Hospital | 30 | 2010-08-01 | 2015-10-26 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity GSK1358820(Botulinum toxin type A), placebo - Cerebrovascular Accident | Phase 3 | Completed | GlaxoSmithKline | 170 | 2010-04-01 | 2017-06-28 |
| The Effect of an Aerobic Exercise Programme in Stroke Patients Aerobic exercise group, Control group, Follow-up first aerobic exercise group - Cerebrovascular Accident | Phase 3 | Unknown | University College of Antwerp | 50 | 2010-02-01 | 2010-04-14 |
| Norwegian Constraint-Induced (CI) Therapy Multisite Trial Modified CI therapy - Cerebrovascular Accident | Phase 3 | Terminated | University Hospital of North Norway | 47 | 2008-10-01 | 2013-10-10 |
| Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183) Vorapaxar 2.5 mg, Placebo - Atherosclerosis, Ischemia | Phase 3 | Completed | Merck Sharp & Dohme LLC | 258 | 2008-07-01 | 2018-09-21 |
| Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034) Telcagepant, Acetaminophen/Paracetamol, Placebo to Telcagepant - Migraine Disorders, Heart Disease | Phase 3 | Completed | Merck Sharp & Dohme LLC | 165 | 2008-03-17 | 2018-10-19 |
| Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia Melodic Intonation Therapy, Speech-Repetition-Therapy - Aphasia, Stroke | Phase 3 | Completed | Beth Israel Deaconess Medical Center | 30 | 2008-02-01 | 2020-09-21 |
| Intra-arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke Alteplase IA and/or mechanical thrombolysis, Alteplase IV - Stroke, Cerebrovascular Accident | Phase 3 | Completed | Niguarda Hospital | 350 | 2008-02-01 | 2014-04-25 |
| Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737) Vorapaxar, Placebo - Atherosclerosis, Ischemia | Phase 3 | Completed | Merck Sharp & Dohme LLC | 26449 | 2007-09-01 | 2018-09-21 |
| Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity GSK1358820, Placebo - Post-Stroke Spasticity, Cerebrovascular Accident | Phase 3 | Completed | GlaxoSmithKline | 109 | 2007-05-01 | 2017-05-30 |
| Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity GSK1358820, Placebo - Post-Stroke Spasticity, Cerebrovascular Accident | Phase 3 | Completed | GlaxoSmithKline | 120 | 2007-05-01 | 2010-09-08 |
| Stroke With Transfusions Changing to Hydroxyurea Red Cell Transfusions, Iron Chelation, Hydroxyurea - Hemochromatosis, Cerebrovascular Accident | Phase 3 | Terminated | St. Jude Children's Research Hospital | 134 | 2006-10-01 | 2013-01-18 |
| JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme Aggrenox capsule, Acetylsalicylic Acid (ASA) - Cerebrovascular Accident | Phase 3 | Completed | Boehringer Ingelheim | 1295 | 2006-04-01 | 2014-02-14 |
| Niacin Plus Statin to Prevent Vascular Events Extended release niacin, Simvastatin - Cardiovascular Diseases, Heart Diseases | Phase 3 | Terminated | Axio Research. LLC | 3414 | 2005-09-01 | 2016-04-06 |
Showing 20 of 36. Sign in to see all of them.
Stroke (36) · Muscle Spasticity (8) · Heart Diseases (5) · Cardiovascular Diseases (4) · Ischemic Stroke (4) · Myocardial Infarction (4) · Atherosclerosis (3) · Hematologic Diseases (3) · Ischemia (3) · Anemia, Sickle Cell (2) · Arrhythmias, Cardiac (2) · Atrial Fibrillation (2) · Brain Ischemia (2) · Cerebrovascular Disorders (2) · Vascular Diseases (2)
Brain Diseases (36) · Central Nervous System Diseases (36) · Nervous System Diseases (36) · Cerebrovascular Disorders (34) · Vascular Diseases (34) · Cardiovascular Diseases (32) · Pathological Conditions, Signs and Symptoms (20) · Pathologic Processes (12) · Neurologic Manifestations (9) · Signs and Symptoms (9) · Muscle Hypertonia (8) · Muscular Diseases (8) · Musculoskeletal Diseases (8) · Neuromuscular Manifestations (8) · Infarction (6)
Botulinum Toxins, Type A (5) · Botulinum Toxins (3) · Aspirin (2) · Constraint Induced Movement Therapy (2) · vorapaxar (2) · Abciximab (1) · Acetaminophen (1) · Amiodarone (1) · Aspirin, Dipyridamole Drug Combination (1) · Blood Transfusion (1) · Clinical Trials, Phase II as Topic (1) · Clinical Trials, Phase III as Topic (1) · Clopidogrel (1) · Control Groups (1) · Disulfides (1)
Boehringer Ingelheim (3) · Chang Gung Memorial Hospital (3) · GlaxoSmithKline (3) · Merck Sharp & Dohme LLC (3) · Niguarda Hospital (2) · Axio Research. LLC (1) · Beth Israel Deaconess Medical Center (1) · Centocor, Inc. (1) · CoAxia (1) · Emory University (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Jeffrey L. Saver (1) · Lanzhou Institute of Biological Products Co., Ltd (1) · Massachusetts General Hospital (1) · Mt. Sinai Medical Center, Miami (1)
United States (12) · Canada (5) · Taiwan (5) · Belgium (3) · Hungary (3) · Italy (3) · Japan (3) · Spain (3) · Switzerland (3) · Austria (2) · Germany (2) · Norway (2) · Poland (2) · Chile (1) · China (1)
Pong Ya-Ping, MD (3) · Alfonso Ciccone, MD (2) · Ajay K Nooka (1) · Andrea Norton, BM (1) · Ashfaq Shuaib, MD (1) · Audny GM Anke, MD, PhD (1) · Bent Indredavik, MD, PhD (1) · Bramah N. Singh (1) · Bryan Due, Ph.D. (1) · Daniel Kiper, PD PhD (1) · Dirk Vissers, dr. (1)
PMID 35224730, PMID 12914883, PMID 16382063, PMID 17077374, PMID 18032739, PMID 18077218, PMID 18815396, PMID 19673813, PMID 19699854, PMID 19721013, PMID 19850525, PMID 20358216, PMID 20446946, PMID 20569068, PMID 20814005, PMID 21197418, PMID 21371282, PMID 21372306, PMID 21502757, PMID 21566232, PMID 21826782, PMID 21899409, PMID 21990564, PMID 22085343, PMID 22168590, PMID 22221076, PMID 22318199, PMID 22443427, PMID 22499292, PMID 22750086, PMID 22826359, PMID 22931315, PMID 22932716, PMID 23034910, PMID 23291425, PMID 23387822, PMID 23396280, PMID 23501976, PMID 23549132, PMID 23726159, PMID 23736109, PMID 23828106, PMID 23861242, PMID 23881958, PMID 23916935, PMID 23973688, PMID 24177006, PMID 24523037, PMID 24661819, PMID 24862645
P30CA138292 (1), R01DC008796 (1), R01HL033233 (1), U01HL049804 (1), U01HL052016 (1), U01HL073958 (1), U01HL074815 (1), U01HL078787 (1), U01HL081616 (1), U01HL081649 (1), U01NS044364 (1)